Literature DB >> 12447690

Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion.

Yuequin Liu1, Borko Jovanovic, Michael Pins, Chung Lee, Raymond C Bergan.   

Abstract

The regulation of cell adhesion and motility in human prostate is not well understood. We have previously shown that the endoglin gene is differently expressed during changes in prostate cell adhesion. Endoglin is a transmembrane transforming growth factor beta binding protein typically expressed by endothelial cells. In this report we demonstrate that endoglin over expression increases prostate cell attachment, while decreasing migration and invasion. Engineered decreases in endoglin expression have opposite effects. While endoglin exerted only relatively small effects upon cell adhesion, large effects upon cell migration and invasion were observed. Endoglin was shown to localize to focal adhesion plaques, consistent with its role in regulating cell adhesion and motility. Loss of endoglin expression in cancer, as compared to normal prostate, was seen in human prostate cell lines. Suppression of endoglin expression in a panel of normal human prostate cell lines led to cell detachment. Endoglin is identified as a regulator of cell adhesion, motility and invasion in human prostate. Loss of endoglin expression appears to be associated with prostate cancer progression, at least in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447690     DOI: 10.1038/sj.onc.1206117

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  Endoglin suppresses human prostate cancer metastasis.

Authors:  Minalini Lakshman; Xiaoke Huang; Vijayalakshmi Ananthanarayanan; Borko Jovanovic; Yueqin Liu; Clarissa S Craft; Diana Romero; Calvin P H Vary; Raymond C Bergan
Journal:  Clin Exp Metastasis       Date:  2010-10-28       Impact factor: 5.150

2.  The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.

Authors:  Xingding Zhang; Yu Jing; Yang Qin; Sally Hunsucker; Huimin Meng; Jun Sui; Yelin Jiang; Li Gao; Gangli An; Nan Yang; Robert Z Orlowski; Lin Yang
Journal:  Int J Biochem Cell Biol       Date:  2012-04-16       Impact factor: 5.085

3.  The methodology used to measure differential gene expression affects the outcome.

Authors:  Yongzeng Ding; Li Xu; Borko D Jovanovic; Irene B Helenowski; David L Kelly; William J Catalona; Ximing J Yang; Michael Pins; Raymond C Bergan
Journal:  J Biomol Tech       Date:  2007-12

4.  Endoglin regulates cancer-stromal cell interactions in prostate tumors.

Authors:  Diana Romero; Christine O'Neill; Aleksandra Terzic; Liangru Contois; Kira Young; Barbara A Conley; Raymond C Bergan; Peter C Brooks; Calvin P H Vary
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

5.  Soluble CD105 is prognostic of disease recurrence in prostate cancer patients.

Authors:  Veronica R Placencio-Hickok; Anisha Madhav; Sungjin Kim; Frank Duong; Bryan Angara; Zhenqiu Liu; Neil A Bhowmick
Journal:  Endocr Relat Cancer       Date:  2020-01       Impact factor: 5.678

6.  TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.

Authors:  Luisa M Botella; Francisco Sanz-Rodriguez; Yusuke Komi; Africa Fernandez-L; Elisa Varela; Eva M Garrido-Martin; Goutham Narla; Scott L Friedman; Soichi Kojima
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

Review 7.  Inhibition of cancer cell invasion and metastasis by genistein.

Authors:  Janet M Pavese; Rebecca L Farmer; Raymond C Bergan
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

8.  Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.

Authors:  C S Craft; D Romero; C P H Vary; R C Bergan
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

9.  Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia.

Authors:  Christine W Duarte; Kimberly Murray; F Lee Lucas; Kathleen Fairfield; Heather Miller; Peter Brooks; Calvin P H Vary
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-05       Impact factor: 4.254

10.  Inherent phenotypic plasticity facilitates progression of head and neck cancer: endotheliod characteristics enable angiogenesis and invasion.

Authors:  Meng Tong; Byungdo B Han; Andrew S Holpuch; Ping Pei; Lingli He; Susan R Mallery
Journal:  Exp Cell Res       Date:  2013-01-29       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.